Survey Demolishes the Cannabis Is a Gateway Drug Myth

A Survey in Argentina has demolished the myth that cannabis is a gateway drug. The survey found that, while cannabis users consume other psychoactive substances, fundamentally alcohol (80%) and tobacco (46%), when it came to the use of harder substances such as cocaine (2.5%), cannabis users were no different to the general population.

These were the findings of the Argentinian First National Survey of People Who Use Cannabis. The specialist magazine THC conducted the survey in partnership with the Center for the Study of the Argentine Cannabis Culture (CECCA) and the National University of Quilmes (UNQ).

For more news like this, download our free cannabis news app.

Cannabis Use Facts

The survey also showed that flowers or buds are the primary formats for cannabis consumption (93%), followed by pressing (27%), oil (20%), food (11.4%), creams (9.6%), and extractions (6.4%).

“These results show that the use of derivative products is no longer something strange and that today the vast majority (of users) at least interact with them. This was much less common ten years ago and practically exceptional 15 years ago,” said Emiliano Flores, director of the study and researcher at CECCA.

“On the other hand, although the prevalence of flowers and buds is still high in general terms when you disaggregate the data by type of use, among medicinal cannabis users, pressing is in fourth place, below creams and oil,” he added.

Medical Cannabis Alternative to Other Drug Treatments

Regarding the diagnosed diseases for which medical cannabis is used, anxiety (26%), depression (14.6%), migraines (10%), osteoarthritis (6%), hypertension (5.5%), and arthritis (4.5%) stand out. %) and fibromyalgia (3.8%).

On the other hand, 9 out of 10 people who use cannabis – whether for recreational or medicinal purposes – start doing so before the age of 25, and 4 out of 10 before the age of 18.

“In general, it is an early starting age. But the survey shows that this does not become a problem for poly drug use because the use of other substances (at the same time as cannabis), at least illegal ones, is very low,” Flores said.

Survey Proves Cannabis Is not a Gateway Drug

“This knocks down a bit the myth of (cannabis as) a gateway drug and, in particular, cocaine recently appears in sixth place, almost on the same level as mushrooms,” he added.

The report is based on an online survey answered by 64,646 people between the ages of 16 and 92 from all provinces who used cannabis at least once in the year prior to the survey (in 2020). The preliminary results had already been presented in October at the last Cannabis Expo.

These first conclusions showed that 75.5% of the people who treat a health problem with medical cannabis managed to reduce the consumption of other drug based treatments, and almost all (98%) claimed to have improved their quality of life in this way. However, only two out of ten had a doctor to accompany them in this process.

Findings on Self-Cultivation

Another aspect to highlight is that a quarter of cannabis users access this product from self-cultivation, and in almost 90% of cases, they did so feeling fear of being prosecuted at least once.

Among other data, the study showed that although 75% of users access cannabis in ways other than self-cultivation (48.2% buy it, 17.2% by gift, and 8% by collective cultivation), 9 out of 10 would like to have their own plants.

As for the reasons that led them to give up this idea, 72.9% pointed out the fear of legal conflicts with neighbors or with relatives.

“Those who engage in medicinal use are the ones who self-cultivate the most. Additionally, self-cultivation is more masculinized and more frequent among generation X. Buying on the gray market is more common among millenials and older adults,” he explained.

—

(Featured image by Gras Grün via Unsplash)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published by Diario El Argentino, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions, or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.